Founding Members of CLIMADE consortium

 

Climate Amplified Diseases and Epidemics (CLIMADE): A global consortium led by the global south to study and respond to Climate Amplified Diseases and Epidemics.

CLIMADE (Climate Amplified Diseases & Epidemics), a consortium of leading global scientists focused on bridging knowledge gaps, improving surveillance tools and expanding adequate interventions to decrease the impact of climate amplified diseases and epidemics.

The overarching long-term goal of CLIMADE is to predict, track and control diseases and epidemics that are amplified by human-caused climate change in the most affected countries in the world. CLIMADE will leverage the medical, scientific, and public health experience of epidemiology, ecology and evolution in the global south to establish a robust disease surveillance system, with which to quickly identify pathogens and track their evolution and spread, to control outbreaks before they become epidemics and epidemics before they become pandemics.

 

The CLIMADE consortium brings together partners in the globe that have long term experience working with climate amplified epidemics and pathogens’ genomics. Partners include public health agencies, academic organizations, and industry.  The CLIMADE consortium is led by Prof. Tulio de Oliveira, from the Centre for Epidemic Response and Innovation (CERI) in South Africa, Prof. Luiz Carlos Alcantara, from the Fundação Osvaldo Cruz (FIOCRUZ) in Brazil and Prof. Edward C Holmes (Univ Sydney) in Australia. Together, with an stirring committee, they lead the implementation of the global consortium. 

Together, with key public health agencies, such as the Africa CDC and the WHO/PAHO, we bring decades of experience in genomics surveillance and epidemic response and managed to assemble a world leading team of academic and industrial experts with the support from public health institutes and initial funding to start developing the global network. 

services

Our philosophy

our mission
To use the medical, scientific, and public health experience of epidemics in the global south to help the world to create a robust surveillance system to quickly identify pathogens and track their evolution and spread to control outbreaks before they become epidemics and epidemics before they become pandemics
To develop tools to predict, track and control diseases and epidemics in the most affected countries in the world.  To use this data to prevent new epidemics and pandemics that can be amplified by climate change
A recent systematic review found that more than half of known infectious diseases will be aggravated by climate hazards, the majority of which are vector borne.
IMPORTANT MILESTONES

What we
accomplished

scientists
0
pathogens
0
Partners
0
countries
0
services

Our philosophy

our mission
To use the medical, scientific, and public health experience of epidemics in the global south to help the world to create a robust surveillance system to quickly identify pathogens and track their evolution and spread to control outbreaks before they become epidemics and epidemics before they become pandemics
To develop tools to predict, track and control diseases and epidemics in the most affected countries in the world.  To use this data to prevent new epidemics and pandemics that can be amplified by climate change
A recent systematic review found that more than half of known infectious diseases will be aggravated by climate hazards, the majority of which are vector borne.
IMPORTANT MILESTONES

What we
accomplished

FINISHED PROJECTS
0
Design awards
0
Years in industry
0
HAPPY CLIENTS
0
TEAM

steering committe

The CLIMADE consortium brings together partners from across the globe that have long-term experience working with climate amplified epidemics and pathogen genomics. Partners include public health agencies, academic organizations, and industry. 

Prof Tulio de Oliveira

Director of CERI, SU
South Africa/Brazil
Tulio2023-2

Dr Cheryl Baxter

CERI, Stellenbosch University
South Africa
cheryl

Dr Houryiiah Tegally

CERI, Stellenbosch University,
South Africa/Mauritius
Tegally

Dr Monika Moir

CERI, Stellenbosch University
South Africa
Moir

Prof Edward C Holmes

University of Sydney
Australia/U.K.
Eddie_350

Dr Tanya Golubchik

University of Sydney
Australia
Tanya2

Dr Samuel Oyola

International Livestock Research Institute, Kenya
samuel

Dr Vagner Fonseca

University of State of Bahia, Brazil
CERI Staff-5_low

Dr Marta Giovanetti

Università Campus Bio-Medico, RM, Italy
Fiocruz Foundation/Brazil
Marta2

Dr José Lourenço

Universidade de Católica de Lisboa
Portugal
joseLourenco

Prof Frank Tanser

Spatial Epidemiologist, South Africa
FrankTanser

Prof. Luiz Alcantara

FioCruz Foundation
Brazil
WhatsApp Image 2023-05-21 at 17.10.34

CLIMADE Collaborators that contributed to the COP28 report: 

 – Ambroise Ahouidi (Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formations (IRESSEF), Senegal)),
 – Abdou Padane (IRESSEF, Senegal),
 – Abdualmoniem Omer Abdalla Musa (General Administration of Laboratories and Blood Banks, Ministry of Health, Kassala state, Sudan),
 – Adugna Abera (Ethiopian Public Health Institute, Ethiopia),
 – Allan Campbell (Central Public Health Reference Laboratory, Sierra Leone),
 – Aloysious Ssemaganda (National Health Laboratories and Diagnostic Services – Central Public Health Laboratories, Uganda),
 – Argentina Felisbela Muianga (Instituto Nacional de Saude, Mozambique),
 – Aziza John Samson (Tanzania),
 – Bernard Onoja (University of Ibadan, Nigeria),
 – Birhanu Desta Alemu (PATH, Ethiopia),
 – Darren Martin (University of Cape Town, South Africa),
 – Mohamed Zahir Alimohamed (Muhimbili University of Health and Allied Sciences, Tanzania),
 – Fredy Brice Nemg Simo (Centre for Research in Infectious Disease, Cameroon),
 – Girma Godebo, Wachemo University, Ethiopia),
 – James Ayei Maror (National Public Health Laboratory, South Sudan, John Oludele (Instituto Nacional de Saude, Mozambique),
 – Joseph Fokam (Chantal BIYA International Reference Centre, Cameroon),
 – Kenneth K Maeka (National Microbiology Reference Laboratory, Ministry of Health, Zimbabwe),
 – Lavanya Singh (KRISP, University of KwaZulu-Natal, South Africa),
 – Martin Faye (Institut Pasteur de Dakar, Senegal),
 – Michael Owusu (Kwame Nkrumah University of Science and Technology, Ghana),
 – Michel Ngonga Dikongo (Biologiste, Gabon),
 – Molalegne Bitew (Bio and Emerging Technology Institute, Ethiopia),
 – Nkuurunziza Jerome (Hope Africa University, National Institute of Public Health Reference Laboratory, Burundi),
 – Nokuzola Mbhele (University of Cape Town, South Africa),
 – Oyewale Tomori (ACEGID-RUN, Nigeria),
 – Ramuth Magalutcheemee (Ministry of Health, Mauritius),
 – Sara Abdelrahman Abuelmaali (National Public Health Laboratory, Sudan),
 – Wolfgang Preiser (University of Stellenbosch / National Health Laboratory Service, Tygerberg, South Africa)